Monitor the Annual Meeting vote results for any significant withhold votes against director nominees (unlikely given incumbents' large ownership positions). Watch for any subsequent 8-K or Form 4 filings related to the $10.0M promissory note repayment or additional financing activity by GKCC LLC.
Price Chart
Executive Summary
Elicio Therapeutics filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on November 12, 2026. The meeting will feature the election of three director nominees (Julian Adams, Jay Venkatesan, Carol Ashe) and ratification of Baker Tilly US, LLP as independent auditor. The filing is routine with no shareholder proposals, contested elections, or material governance changes.
Key Facts
- Annual Meeting scheduled for November 12, 2026, held virtually via live webcast
- Three director nominees: Julian Adams (Chairman), Jay Venkatesan, Carol Ashe — all incumbents standing for re-election to three-year terms
- Board recommends FOR all director nominees and FOR ratification of Baker Tilly as auditor
- No shareholder proposals on the ballot
- CEO Robert Connelly total 2025 compensation: $1,887,660 (salary $632,700 + option awards $906,960 + bonus $348,000)
- CFO Preetam Shah (hired March 2025) total 2025 compensation: $1,377,686 (prorated salary $350,612 + option awards $796,143 + bonus $201,600 + other $29,331)
- CMO Christopher Haqq total 2025 compensation: $1,078,176 (salary $528,100 + option awards $328,176 + bonus $221,900)
- Director Katie Chudnovsky beneficially owns 31.1% of outstanding shares; GKCC LLC (controlled by Chudnovsky) holds 23.2%
- Related party transactions: $10.0M senior secured promissory note from GKCC LLC (June 2025, 12.5% interest rate, $10.0M outstanding as of proxy date
- 27,091,187 shares outstanding as of record date September 17, 2026
- Audit fees for FY2025: $572,069 (vs $567,800 in FY2024)
Financial Impact
No material financial impact from this routine proxy filing. CEO total compensation $1.89M, CFO $1.38M, CMO $1.08M for FY2025. Related party debt: $10.0M promissory note outstanding at 12.5% interest.
Risk Factors
- Director Katie Chudnovsky's 31.1% beneficial ownership and GKCC LLC's 23.2% stake create significant related party concentration risk
- $10.0M secured promissory note at 12.5% interest with first lien on substantially all assets and intellectual property represents material debt burden for a clinical-stage biotech
- No shareholder proposals or say-on-pay vote on the ballot — no investor discontent signal is measurable
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001601485-26-000061 |
| Document: 0001601485-26-000061-index-headers.html | 0001601485-26-000061 |
| Document: 0001601485-26-000061-index.html | 0001601485-26-000061 |
| Document: 0001601485-26-000061.txt | 0001601485-26-000061 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | DEF 14A | $1.88 | awaiting T+60 | — | $1.70 (−9.57%) |
Sep 22, 2026 4w ago | Institutional Cluster | $1.87 | awaiting T+60 | — | $1.70 (−9.09%) |
Jul 2, 2026 16w ago | 424B5 | $3.22 $1.88 | ▲ +41.61% | ▲ +44.62% | $1.70 (+47.20%) |
Jul 2, 2026 16w ago | 8-K | $3.22 $1.88 | ▲ +41.61% | ▲ +44.62% | $1.70 (+47.20%) |
Jun 24, 2026 17w ago | 8-K | $3.75 $1.89 | ▼ −49.60% | ▼ −53.33% | $1.70 (−54.67%) |
Jun 17, 2026 18w ago | 8-K | $4.71 $2.05 | ▼ −56.48% | ▼ −59.62% | $1.70 (−63.91%) |
May 11, 2026 24w ago | 8-K | $10.55 $3.14 | ▼ −70.24% | ▼ −74.62% | $1.70 (−83.89%) |
Mar 17, 2026 31w ago | EFFECT | $12.18 $14.20 | ▲ +16.58% | ▲ +6.72% | $1.70 (−86.04%) |
Mar 12, 2026 32w ago | Press Release | $12.20 $13.55 | ▲ +11.07% | ▼ −0.55% | $1.70 (−86.07%) |
Mar 2, 2026 33w ago | S-3/A | $12.50 $10.77 | ▲ +13.84% | ▲ +24.16% | $1.70 (+86.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers